Brief: Curanex Pharmaceuticals Announces Pricing Of Its Initial Public Offering
26/08/2025 12:31
Aug 26 (Reuters) - Curanex Pharmaceuticals Inc CURX.O: CURANEX PHARMACEUTICALS INC. ANNOUNCES PRICING OF ITS INITIAL PUBLIC OFFERING CURANEX PHARMACEUTICALS INC - OFFERING OF 3,750,000 SHARES AT $4.00 PER SHARE CURANEX PHARMACEUTICALS INC - PROCEEDS TO DEVELOP PHYTO-N FOR ULCERATIVE COLITIS Source text: ID:nGNX5H9GsJ Further company coverage: CURX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Curanex Pharmaceuticals
See all newsBrief: Curanex Pharmaceuticals - Securities Class Action Filed Against Curanex Pharmaceuticals And Underwriters On July 23, 2026 - SEC Filing
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Curanex Pharmaceuticals Advancing Phyto-N Toward A Planned Investigational New Drug Submission To FDA For Ulcerative Colitis In Q4 2026